0 Comments
0 Shares
5 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Buprenorphine Market Growth Is Driven By Increasing Prescription Of Opioid Addiction TherapyThe Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...0 Comments 0 Shares 1190 Views 0 Reviews
- Buprenorphine Market Growth Is Driven By Increasing Prescription Of Opioid Addiction TherapyThe Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...0 Comments 0 Shares 1159 Views 0 Reviews
- Buprenorphine Market Size, Analysis and Forecast 2031The Buprenorphine Market in 2023 is US$ 5.51 billion, and is expected to reach US$ 17.1 billion by 2031 at a CAGR of 15.20%. FutureWise Research published a report that analyzes Buprenorphine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and...0 Comments 0 Shares 549 Views 0 Reviews
- North America segment contributes over 35% of global buprenorphine market shareMarket Overview: The global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2022 and is expected to exhibit a CAGR of 14.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Buprenorphine is a partial opioid agonist used to treat opioid addiction and pain. It provides an effective alternative to methadone for...0 Comments 0 Shares 1491 Views 0 Reviews
- Sublingual Film is fastest growing segment fueling the growth of Buprenorphine MarketMarket Overview: Buprenorphine is commonly used as a medication-assisted treatment for opioid use disorder. It helps reduce cravings and withdrawal symptoms without causing the euphoric feeling or toxicity associated with full opioid agonists. The growing prevalence of opioid addiction worldwide coupled with supportive government initiatives regarding medication-assisted therapies are fueling...0 Comments 0 Shares 1809 Views 0 Reviews
- The Buprenorphine Market is driven by increasing opioid addiction and misuse casesThe buprenorphine market comprises drugs that are primarily used to treat opioid addiction and misuse. Buprenorphine is a partial opioid agonist used as an alternative to methadone for medication-assisted treatment (MAT) of opioid dependence. It binds to the same opioid receptors as other opioids like heroin and morphine but has a ceiling effect, which restricts its euphoric and respiratory...0 Comments 0 Shares 43 Views 0 Reviews
- The Buprenorphine Market is driven by increasing opioid addiction and misuse casesThe buprenorphine market comprises drugs that are primarily used to treat opioid addiction and misuse. Buprenorphine is a partial opioid agonist used as an alternative to methadone for medication-assisted treatment (MAT) of opioid dependence. It binds to the same opioid receptors as other opioids like heroin and morphine but has a ceiling effect, which restricts its euphoric and respiratory...0 Comments 0 Shares 43 Views 0 Reviews
- The Buprenorphine Market Poised to Witness Significant Growth Owing to Growing Addiction Treatment NeedsThe buprenorphine market involves the use of buprenorphine as an alternative treatment for opioid addiction. Buprenorphine is a partial opioid agonist which helps relieve cravings and withdrawal symptoms without producing the euphoric effects associated with drug abuse. Addiction to prescription painkillers and heroin has risen significantly in recent times, driving the need for more effective...0 Comments 0 Shares 73 Views 0 Reviews
- Future Prospects of Thebaine Market: Increasing Demand for Pain Management Medications Drives Market GrowthSWOT Analysis: Strength: Thebaine market is driven by the increasing demand for pain management drugs and the effectiveness of Thebaine-based opioids in providing pain relief.Weakness: The stringent regulatory framework and the potential for opioid abuse are some of the weaknesses that could limit market growth.Opportunity: The expanding pharmaceutical industry and the rising investments in...0 Comments 0 Shares 1398 Views 0 Reviews
- Future Prospects of Thebaine Market: Increasing Demand for Pain Management Medications Drives Market GrowthSWOT Analysis: Strength: Thebaine market is driven by the increasing demand for pain management drugs and the effectiveness of Thebaine-based opioids in providing pain relief.Weakness: The stringent regulatory framework and the potential for opioid abuse are some of the weaknesses that could limit market growth.Opportunity: The expanding pharmaceutical industry and the rising investments in...0 Comments 0 Shares 1446 Views 0 Reviews
- Opioid Addiction Treatment Market To Witness High Growth Driven By Expanding Patient Base And Increasing R&D ActivitiesBuprenorphine is an opioid medication primarily used to treat opioid use disorder, acute pain, and chronic pain. It is typically taken under the tongue as a film, tablet, or as an injection. Buprenorphine helps to relieve cravings and withdrawal symptoms associated with opioid addiction. The medication works by activating opioid receptors in the brain to relieve pain and reduce opioid cravings...0 Comments 0 Shares 1334 Views 0 Reviews
More Results